Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
22,485,191
-
Share change
-
+578,013
-
Total reported value
-
$521,884,094
-
Price per share
-
$23.21
-
Number of holders
-
80
-
Value change
-
+$15,004,458
-
Number of buys
-
35
-
Number of sells
-
34
Institutional Holders of DECIPHERA PHARMACEUTICALS IN - COM (DCPH) as of Q1 2019
As of 31 Mar 2019,
DECIPHERA PHARMACEUTICALS IN - COM (DCPH) was held by
80 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,485,191 shares.
The largest 10 holders included
New Leaf Venture Partners, L.L.C., ORBIMED ADVISORS LLC, Redmile Group, LLC, MILLENNIUM MANAGEMENT LLC, SV Health Investors, LLC, BlackRock Inc., VANGUARD GROUP INC, JANUS HENDERSON GROUP PLC, ALKEON CAPITAL MANAGEMENT LLC, and STATE STREET CORP.
This page lists
80
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.